TrialTrials2015

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.

Patrick N A Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.